ORAUT-TKBS-0052, Summary Site Profile for the Pacific Proving

ORAUT-TKBS-0052, Summary Site Profile for the Pacific Proving

Page 1 of 33 DOE Review Release 07/25/2016 ORAUT-TKBS-0052 Rev. 01 Summary Site Profile for the Effective Date: 07/11/2016 Pacific Proving Ground Supersedes: Revision 00 Subject Expert(s): Eugene M. Rollins and Kathy Boothe Document Owner Signature on File Approval Date: 06/17/2016 Approval: Eugene M. Rollins, Document Owner Concurrence: Signature on File Concurrence Date: 06/16/2016 John M. Byrne, Objective 1 Manager Concurrence: Signature on File Concurrence Date: 06/15/2016 Edward F. Maher, Objective 3 Manager Concurrence: Vickie S. Short Signature on File for Concurrence Date: 06/16/2016 Kate Kimpan, Project Director Approval: Signature on File Approval Date: 07/11/2016 James W. Neton, Associate Director for Science FOR DOCUMENTS MARKED AS A TOTAL REWRITE, REVISION, OR PAGE CHANGE, REPLACE THE PRIOR REVISION AND DISCARD / DESTROY ALL COPIES OF THE PRIOR REVISION. New Total Rewrite Revision Page Change Document No. ORAUT-TKBS-0052 Revision No. 01 Effective Date: 07/11/2016 Page 2 of 33 PUBLICATION RECORD EFFECTIVE REVISION DATE NUMBER DESCRIPTION 08/30/2006 00 New document to describe the Pacific Proving Ground and other oceanic test locations to enable the preparation of dose reconstructions. First approved issue of Revision 00. Incorporates internal and NIOSH formal review comments. There is no change to the assigned dose and no PER is required. Training required: As determined by the Task Manager. Initiated by Lori J. Arent. 07/11/2016 01 Revision initiated to update occupational medical and external dose information. Added excerpts to Section 1.3 from EEOICPA Bulletin No. 06-15 and EEOICPA Bulletin No. 07-05 clarifying that 83 days of continuous presence on land or ships would be equivalent to the 250-workday requirement for eligibility for compensation. Removed reference in Section 3.0 to ORAUT-PROC-0061 and added evaluation requirements under ORAUT-OTIB-0079. Provided additional information about the assignment of X-ray procedures based on various DOE responses. Revised Section 6.0 requirement to assign 95th-percentile doses from Attachment A for unmonitored workers and added requirement to Attachment A for comparison and assignment of the larger of missed plus recorded dose to the 95th-percentile doses. Removed requirement to assume beta-to- gamma ratios from the Nevada Test Site profile. Added Section 6.1 to provide beta-to-gamma ratios as a function of time after detonation and distance from source plane, which is favorable to claimants. Added Section 6.2 to provide methods for reconstructing dose from fallout from the GREENHOUSE operation for workers on contaminated islands and ships. Added Sections 6.3.1 and 6.3.2 to provide methods for determining penetrating and nonpenetrating dose. Added Section 6.3.3 for determining penetrating and nonpenetrating dose from fallout. Revised Section 7.0 to include all dose reconstruction methods. Incorporates formal internal and NIOSH review comments. Constitutes a total rewrite of the document. Training required: As determined by the Task Manager. Initiated by Eugene M. Rollins. Document No. ORAUT-TKBS-0052 Revision No. 01 Effective Date: 07/11/2016 Page 3 of 33 TABLE OF CONTENTS SECTION TITLE PAGE Acronyms and Abbreviations ............................................................................................................... 5 1.0 Introduction .............................................................................................................................. 7 1.1 Purpose ........................................................................................................................ 8 1.2 Scope ........................................................................................................................... 8 1.3 Special Exposure Cohort .............................................................................................. 8 2.0 Site Description ........................................................................................................................ 9 3.0 Occupational Medical Dose .................................................................................................... 12 4.0 Occupational Environmental Dose ......................................................................................... 13 5.0 Occupational Internal Dose .................................................................................................... 14 6.0 Occupational External Dose ................................................................................................... 14 6.1 Unmonitored Skin Dose Beta-to-Gamma Ratios ......................................................... 18 6.2 Unmonitored Skin Dose from Fallout .......................................................................... 20 6.3 Instructions to Dose Reconstructors ........................................................................... 24 6.3.1 Penetrating Dose Determination .................................................................. 24 6.3.2 Nonpenetrating Dose Determination ............................................................ 24 6.3.3 Penetrating and Nonpenetrating Doses from Fallout .................................... 24 7.0 Summary ............................................................................................................................... 25 8.0 Attributions and Annotations .................................................................................................. 25 References ........................................................................................................................................ 26 Glossary ............................................................................................................................................ 29 ATTACHMENT A COWORKER DOSE ....................................................................................... 31 Document No. ORAUT-TKBS-0052 Revision No. 01 Effective Date: 07/11/2016 Page 4 of 33 LIST OF TABLES TABLE TITLE PAGE 2-1 PPG tests ............................................................................................................................... 10 6-1 External dosimetry using photon-beta dosimeters, 1946 to 1962 ........................................... 15 6-2 Beta-to-gamma dose ratios for bare skin exposures to mixed fission products at PPG test sites at various distances from the source plane ............................................................. 18 6-3 Maximum beta-to-gamma ratios between 12 hours and 2 months after detonation at various distances above the source plane .............................................................................. 19 6-4 Anatomical distances to source plane and corresponding beta-to-gamma ratios ................... 19 6-5 Efficiency beta-to-gamma ratios for fresh and weathered fallout ............................................ 20 6-6 Operation Greenhouse fallout exposures for personnel aboard ships for the entire test period ..................................................................................................................................... 24 A-1 Actual film badge readings for Operation Crossroads ............................................................ 32 A-2 Film badge readings for non-DOD participants for Operation Sandstone ............................... 32 A-3 Film badge readings for non-DOD participants for Operation Greenhouse ............................. 32 A-4 Film badge readings for non-DOD participants for Operation Ivy............................................ 32 A-5 Film badge readings for non-DOD participants for Operation Castle ...................................... 33 A-6 Film badge readings for non-DOD participants for Operation Wigwam................................... 33 A-7 Film badge readings for non-DOD participants for Operation Redwing .................................. 33 A-8 Film badge readings for non-DOD participants for Operation Hardtack I ................................ 33 A-9 Film badge readings for non-DOD participants for Operation Dominic I ................................. 33 LIST OF FIGURES FIGURE TITLE PAGE 6-1 Cumulative dose for personnel on Parry Island due to Operation Greenhouse fallout ............ 21 6-2 Cumulative dose for personnel on Enewetak Island due to Operation Greenhouse fallout ..... 22 6-3 Cumulative dose for personnel on Japtan Island due to Operation Greenhouse fallout .......... 23 Document No. ORAUT-TKBS-0052 Revision No. 01 Effective Date: 07/11/2016 Page 5 of 33 ACRONYMS AND ABBREVIATIONS AEC U.S. Atomic Energy Commission AWE atomic weapons employer cm centimeter d day DOD U.S. Department of Defense DOE U.S. Department of Energy DOL U.S. Department of Labor EEOICPA Energy Employees Occupational Illness Compensation Program Act of 2000 EG&G Edgerton, Germeshausen, and Grier ft foot GSD geometric standard deviation H&N Holmes & Narver hr hour in. inch keV kiloelectron-volt km kilometer kt kiloton LANL Los Alamos National Laboratory LLNL Lawrence Livermore National Laboratory MDL minimum detection limit mi mile mo month MPE maximum permissible exposure mR milliroentgen mrem millirem Mt megaton NIOSH National Institute for Occupational Safety and Health NTS Nevada Test Site ORAU Oak Ridge Associated Universities PPG Pacific Proving Ground R roentgen SEC Special Exposure Cohort SNL Sandia National Laboratory SRDB Ref ID Site Research Database Reference Identification (number) t ton Document No. ORAUT-TKBS-0052 Revision No. 01 Effective Date: 07/11/2016 Page 6 of 33 TBD technical

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    33 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us